Penicillin allergy assessment and testing: worth the risk in critically ill patients
Crossref DOI link: https://doi.org/10.1007/s00134-025-08034-5
Published Online: 2025-07-16
Published Print: 2025-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Keane, Sean
Leone, Marc
Martin-Loeches, Ignacio https://orcid.org/0000-0002-5834-4063
Text and Data Mining valid from 2025-07-16
Version of Record valid from 2025-07-16
Article History
Received: 30 April 2025
Accepted: 7 July 2025
First Online: 16 July 2025
Declarations
:
: ML served as speaker for AOP Pharma, Viatris, Edwards Life Science, Grifols, and Shionogi and as consultant for BioMerieux.